# MBRA 3.0: integrating the mucus environment for advanced high-throughput in vitro intestinal microbiome modeling

**Authors:** Maeva Duquesnoy, Benoit Chassaing

PMC · DOI: 10.1080/19490976.2026.2612804 · Gut Microbes · 2026-01-11

## TL;DR

MBRA 3.0 is a new lab system that models the gut's mucus layer to study how microbes interact with it, revealing donor-specific effects on microbial communities and inflammation.

## Contribution

MBRA 3.0 introduces a scalable in vitro system that integrates mucus-coated carriers to model spatial microbiome dynamics and mucus-microbiota interactions.

## Key findings

- Mucus addition alters microbial community structure and metabolic output in a donor-dependent manner.
- MBRA 3.0 supports stable, distinct mucus-associated and luminal communities, reflecting in vivo spatial heterogeneity.
- The system modulates SCFA profiles and inflammatory signatures, emphasizing the importance of spatial context in gut microbiota research.

## Abstract

The colonic mucus layer is a dynamic barrier that plays central roles in intestinal health, and recent studies highlight that it harbors a distinct and functionally critical microbial community. However, most in vitro gut models fail to recapitulate this mucosal niche, limiting mechanistic investigation of microbiota–mucus interactions. Here, we developed the MBRA 3.0 system, a next-generation chemostat engineered to integrate mucus-coated carriers and enable high-throughput dissection of spatial microbiome dynamics. Using fecal microbiota from eight human donors, we report that mucus addition does not impact total bacterial density but selectively shapes microbial community structure, metabolic output, and pro-inflammatory potential in a donor-dependent manner. Notably, MBRA 3.0 resolves stable, compositionally distinct mucus-associated and luminal communities, mirroring in vivo spatial heterogeneity. Integration of this mucosal niche also modulates short-chain fatty acid (SCFA) profiles and inflammatory signatures, highlighting the relevance of the spatial context for intestinal microbiota research. Hence, MBRA 3.0 offers a scalable and customizable platform to model mucus–microbiota interactions, advancing our understanding of gut ecology and supporting translational discovery in gastrointestinal health and disease.

## Full-text entities

- **Diseases:** gastrointestinal health and disease (MESH:D005767), inflammatory (MESH:D007249)
- **Chemicals:** SCFA (MESH:D005232), luminal (MESH:D010634)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12795259/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12795259/full.md

## References

72 references — full list in the complete paper: https://tomesphere.com/paper/PMC12795259/full.md

---
Source: https://tomesphere.com/paper/PMC12795259